Accessibility Menu
 
Prothena Plc logo

Prothena Plc

(NASDAQ) PRTA

Current Price$10.03
Market Cap$540.48M
Since IPO (2012)+37%
5 Year-57%
1 Year-8%
1 Month+5%

Prothena Plc Financials at a Glance

Market Cap

$540.48M

Revenue (TTM)

$9.68M

Net Income (TTM)

$244.09M

EPS (TTM)

$-4.53

P/E Ratio

-2.21

Dividend

$0.00

Beta (Volatility)

1.40 (Average)

Price

$10.03

Volume

21,200

Open

$9.93

Previous Close

$10.03

Daily Range

$9.93 - $10.13

52-Week Range

$4.32 - $11.69

PRTA: Motley Fool Moneyball Superscore

60

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prothena Plc

Industry

Biotechnology

Employees

67

CEO

Gene G. Kinney, PhD

Headquarters

Dublin, 2, IE

PRTA Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-22%

Net Income Margin

-25%

Return on Equity

-64%

Return on Capital

-76%

Return on Assets

-75%

Earnings Yield

-45.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$540.48M

Shares Outstanding

53.83M

Volume

21.20K

Short Interest

0.00%

Avg. Volume

518.11K

Financials (TTM)

Gross Profit

$5.98M

Operating Income

$184.56M

EBITDA

$197.13M

Operating Cash Flow

$163.58M

Capital Expenditure

$138.00K

Free Cash Flow

$163.72M

Cash & ST Invst.

$307.53M

Total Debt

$13.86M

Prothena Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$21.00K

-99.0%

Gross Profit

$921.00K

-143.4%

Gross Margin

-43.86%

N/A

Market Cap

$540.48M

N/A

Market Cap/Employee

$3.32M

N/A

Employees

163

N/A

Net Income

$21.59M

+62.7%

EBITDA

$20.64M

+68.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$293.67M

-36.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$10.97M

+33.3%

Short Term Debt

$2.89M

+10.6%

Return on Assets

-74.69%

N/A

Return on Invested Capital

-76.11%

N/A

Free Cash Flow

$27.16M

+43.2%

Operating Cash Flow

$27.16M

+43.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FDMT4D Molecular Therapeutics, Inc.
$9.94+4.85%
RIGLRigel Pharmaceuticals, Inc.
$27.36-0.62%
VSTMVerastem, Inc.
$5.48-2.66%
NMRANeumora Therapeutics, Inc. Common Stock
$2.12+6.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.87-0.04%
HOLXHologic
$76.01+0.00%
NOKNokia
$8.89+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.10+0.02%

Questions About PRTA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.